| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 343.00M | — |
| Operating expense | — | — |
| Net income | 122.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INDV returned +51.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +2.8% |
| 1 year | +51.6% |
| 5 years | +178.8% |
| 10 years | +77.3% |
| All-time high | $41.03 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INDV would be worth today ›No. Indivior Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Indivior Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol INDV.
Indivior Pharmaceuticals, Inc. is part of the Healthcare sector.
Indivior Pharmaceuticals, Inc. has a market cap of 4.35B USD, based on the latest quote.
